Fibro Daily

Humira Keeps Adverse Effects Low Over Time

Fibro Daily March 27, 2013

The underlying disease being treated differentiates the extent of serious side effects and malignancies when dealing with long-term immunosuppressive treatment with adalimumab (Humira). However, a new study shows that the rates of these side effects and malignancies are low.

Infections are usually the most-oft reported. For instance, rheumatoid arthritis patients report more cellulitis.

Read more:

Adverse Events with Humira Stay Low Over Time



Powered by Facebook Comments

Tagged with:

Comments are closed.

Login to your account

Can't remember your Password ?

Register for this site!